DHR Potential Buy setupReasons for bullish bias:
- Price bounced from support
- Entry is at breakout of HH
- DOW theory, SL at last HL
Entry Level (CMP): 244.95
Stop Loss Level: 222.23
Take Profit Level 1: 267.67
Take Profit Level 2: 290.39
6.45USD
4.76 BUSD
23.89 BUSD
675.16 M
About DANAHER CORP COM USD0.01
Sector
Industry
CEO
Rainer M. Blair
Website
Headquarters
Washington
Employees (FY)
63 K
Founded
1984
ISIN
US2358511028
FIGI
BBG00JRYD0T8
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
DHR - ATH again soonLeaders lead. Has delivered incredible value to shareholders over the last decade. No reason to doubt why it couldn't continue.
Break out of this the daily range should push it to 270 soon.
Disclaimer: no position yet.
Danaher Corp. | Buy Scenario | Wine and waterDanaher in an interesting spot. We are under a resistance level (Resistance area 1) however the level was engulfed already (see orange marking). Looking to buy into if the following should develop:
1. Price breaks above Buy area 1 i want to see a close and open of a weekly or daily candle atleast.
DHR Sell off Misunderstood.The recent DHR Sell off is Misunderstood IMO.
Thoughts where that the recent weight loss drugs innovation will negate the need for life or medical device support for these patient types.
And while this is true in the short term, it does not negate the requirements - unless a complete reversal of the
DHR, Massive BULLISH Wedge-Formation, Major BREAKOUT Incoming!Hello There!
Welcome to my new analysis of DHR. The stock market is in a really important condition currently as there are many interesting stock gems within the market I have spotted in my analytics backend. One of the interesting gems I recently spotted for a major opportunity on the long side o
Danaher (DHR): Life Sciences GiantA Great Business | Fund Favorite | Danaher is a stock Mutual and Hedge Funds Love | The company has a stellar high-moat M&A-driven business model with strong pricing power and often anti-cyclical customers | Compounder Starts To Look Attractive
Dividend Stock Brilliance | Danaher has a wide-moat bu
watching DHR for a potential short-term bullish trade"Based on 17 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $277.76 with a high forecast of $310.00 and a low forecast of $250.00. The average price target represents a 19.37% change from the last price of $232.69."
- Tipranks
DHR with a bearish outlook following its earnings #StocksThe PEAD projected a bearish outlook for DHR after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0R2B is featured.
Frequently Asked Questions
The current price of 0R2B is 237.20 USD — it has decreased by 0.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange DANAHER CORP COM USD0.01 stocks are traded under the ticker 0R2B.
DANAHER CORP COM USD0.01 is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DANAHER CORP COM USD0.01 has a max estimate of 300.00 USD and a min estimate of 215.00 USD.
0R2B earnings for the last quarter are 2.02 USD whereas the estimation was 1.81 USD which accounts for 11.75% surprise. Estimated earnings for the next quarter are 1.91 USD. See more details about DANAHER CORP COM USD0.01 earnings.
DANAHER CORP COM USD0.01 revenue for the last quarter amounts to 6.87 B USD despite the estimated figure of 6.60 B USD. In the next quarter revenue is expected to reach 6.13 B USD.
Yes, you can track DANAHER CORP COM USD0.01 financials in yearly and quarterly reports right on TradingView.
0R2B stock has fallen by 3.94% compared to the previous week, the month change is a 5.74% fall, over the last year DANAHER CORP COM USD0.01 has showed a 5.57% increase.
Like other stocks, 0R2B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DANAHER CORP COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 63.00 K employees. See our rating of the largest employees — is DANAHER CORP COM USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DANAHER CORP COM USD0.01 EBITDA is 8.24 B USD, and current EBITDA margin is 31.16%. See more stats in DANAHER CORP COM USD0.01 financial statements.